Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Titans of Pharma 2018: An Infographic Snapshot Of The Industry's Top Leaders

Executive Summary

In 2017, the top 15 pharma companies paid their CEOs a total of $251m in salary and other benefits, while reporting net income of $56.5bn. But while income was down 41% on 2016, compensation declined by a more modest 9%. In this infographic, Scrip provides a snapshot of these companies' leaders and the businesses they oversee.

You may also be interested in...



Titans Of Pharma – A Snapshot Of The Industry's Top Leaders, An Infographic

In 2016, the 15 top pharma companies paid their CEOs $276m in total* while those same firms reported a total net income of $96.5bn**. Altogether these companies had a market capitalization of $2,238bn on June 30, 2017**. In this infographic Scrip gives a snapshot of these companies' leaders and the businesses they oversee.

Gaming Whiz Brings AI Smarts To Drug Discovery

GlamorousAI is developing technology to uncover new targets and take on previously intractable disease challenges. Founder Noor Shaker hopes to license a drug to big pharma within the next three years.

The Top 10 Best-Selling Drugs of 2019

INFOGRAPHIC: In 2019, 10 blockbuster medicines booked combined sales of $92.5bn. This infographic examines those drugs that commanded the greatest revenues globally, and answers some key questions. Which therapeutic areas include the most lucrative blockbusters? Which companies enjoyed their spoils? And which drugs were new to the top 10 last year? It also takes a look at the position of these products on the all-important US market. 

Topics

Related Companies

UsernamePublicRestriction

Register

SC143384

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel